Early－Phase Drug Development Service:
Phase I Clinical Trials Program

LatestNews

• 

  202507/08

  AbbVie ABBV-324 -First Administration of Investigational Cancer Drug in Asia (Global...

  View More

• 

  202506/17

  Boehringer Ingelheim BI770371’s NCT06806852 trial – the “First patient i...

  View More

• 

  202505/30

  Selected to be AbbVie’s Phase 1 Partnerships for Excellence in Research (P1PER) Glob...

  View More